Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer

Cancer Research

Volumn 62, Issue 23, 2002, Pages 7066-7074

  Kaanders, Johannes H A M ^a   Wijffels, Karien I E M ^a   Marres, Henri A M ^a   Ljungkvist, Anna S E ^a   Pop, Lucas A M ^a   Van den Hoogen, Franciscus J A ^a   De Wilde, Peter C M ^a   Bussink, Johan ^a   Raleigh, James A ^b   Van der Kogel, Albert J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NITROIMIDAZOLE; CARBOGEN; CARBONATE DEHYDRATASE; MARKER; NICOTINAMIDE; PIMONIDAZOLE;

ADULT; AGED; ARTICLE; BLOOD VESSEL; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOXIA; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR LOCALIZATION; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARBON DIOXIDE; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NIACINAMIDE; NITROIMIDAZOLES; OXYGEN; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 0036896722     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Höckel, M., and Vaupel, P. Tumor hypoxia; definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. (Bethesda), 93: 266-276, 2001.
2. Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56: 4509-4515, 1996.
3. Rofstad, E. K. Microenvironment-induced cancer metastasis. Int. J. Radiat. Biol., 76: 589-605, 2000.
4. Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L., and Dewhirst, M. W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys., 38: 285-289, 1997.
5. Nordsmark, M., and Overgaard, J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother. Oncol., 57: 39-43, 2000.
6. Fyles, A., Milosevic, M., Hedley, D., Pintilie, M., Levin, W., Manchul, L., and Hill, R. P. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J. Clin. Oncol., 20: 680-687, 2002.
7. Brizel, D. M, Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., and Dewhirst, M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res., 56: 941-943, 1996.
8. Nordsmark, M., Hoyer, M., Keller, J., Nielsen, O. S., Jensen, O. M., and Overgaard. J. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas. Int. J. Radiat. Oncol. Biol. Phys., 35: 701-708, 1996.
9. Raleigh, J. A., Calkins-Adams, D. P., Rinker, L. H., Ballenger, C. A., Weissler, M. C., Fowler. W. C., Jr., Novotny, D. B., and Varia, M. A. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res., 58: 3765-3768, 1998.
10. Evans, S. M., Hahn, S., Pook, D. R., Jenkins, W. T., Chalian, A. A., Zhang, P., Stevens, C., Weber, R., Weinstein, G., Benjamin, I., Mirza, N., Morgan, M., Rubin, S., McKenna, W. G., Lord, E. M., and Koch, C. J. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res., 60: 2018-2024, 2000.
11. Olive, P. L., Durand, R., E., Raleigh, J. A., Luo, C., and Aquino-Parsons, C. Comparison between the comet assay and pimonidazole binding for measuring tumor hypoxia. Br. J. Cancer, 83: 1525-1531, 2000.
12. Kennedy, A. S., Raleigh, J. A., Perez, G. M., Calkins, D. P., Thrall, D. E., Novotny, D. B., and Varia, M. A. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys., 37: 897-905, 1997.
13. Varia, M. A., Calkins-Adams, D. P., Rinker, L. H., Kennedy, A. S., Novotny, D. B., Fowler, W. C., Jr., and Raleigh, J. A. Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gynecol. Oncol., 71: 270-277, 1998.
14. Wijffels, K. I. E. M., Kaanders, J. H. A. M., Rijken, P. F. J. W., Bussink, J., van den Hoogen, F. J. A., Marres, H. A. M., de Wilde, P. C. M., Raleigh, J. A., and van der Kogel, A. J. Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas. Br. J. Cancer. 83: 674-683, 2000.
15. Sly, W. S., and Hu, P. Y. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu. Rev. Biochem., 64: 375-401, 1995.
16. Ivanov, S., Liao, S. Y., Ivanova, A., Danilkovitch-Miagkova, A., Tarasova, N., Weirich, G., Merrill, M. J., Proescholdt, M. A., Oldfield, E. H., Lee, J., Zavada, J., Waheed, A., Sly, W., Lerman, M. I., and Stanbridge, E. J. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am. J. Pathol., 158: 905-919. 2001.
17. Lal, A., Peters, H., St. Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H. A. M., van der Kogel, A. J., and Riggins, G. J. Transcriptional response to hypoxia in human tumors. J. Natl. Cancer Inst. (Bethesda), 93: 1337-1343, 2001.
18. Olive, P. L., Aquino-Parsons, C., MacPhail, S. H., Liao, S. Y., Raleigh, J. A., Lerman, M. I., and Stanbridge, E. J. Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res., 61: 8924-8929, 2001.
19. Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Simopoulos, K., Pastorek, J., Wykoff, C. C., Gatter, K. C., and Harris, A. L. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin. Cancer Res., 7: 3399-3403, 2001.
20. Chia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., Gatter, K. C., Ratcliffe, P., and Harris, A. L. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J. Clin. Oncol. 19: 3660-3668, 2001.
21. Giatromanolaki, A., Koukourakis, M. I., Sivridis, E., Pastorek, J., Wykoff, C. C., Gatter, K. C., and Harris, A. L. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res., 61: 7992-7998, 2001.
22. Loncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wykoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., and West, C. M. L. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res., 61: 6394-6399, 2001.
23. Kaanders, J. H. A. M., Pop, L. A. M., Marres, H. A. M., Bruaset, I., van den Hoogen, F. J. A., Merkx, M. A. W., and van der Kogel, A. J. ARCON: Experience in 215 patients with advanced head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 52: 769-778, 2002.
24. Azuma, C., Raleigh, J. A., and Thrall, D. E. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime. Radiat. Res., 148: 35-42, 1997.
25. Schlingemann, R. O., Dingjan, G. M., Emeis, J. J., Blok, J., Warnaar, S. O., and Ruiter, D. J. Monoclonal antibody PAL-E specific for endothelium. Lab. Investig., 52: 71-76, 1985.
26. Rijken, P. F. J. W., Bernsen, H. J. J. A., and van der Kogel, A. J. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc. Res., 50: 141-153, 1995.
27. Rijken, P. F. J. W., Bernsen, H. J. J. A., Peters, J. P. W., Hodgkiss, R. J., Raleigh, J. A., and van der Kogel, A. J. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: A quantitative multi-parameter analysis. Int. J. Radiat. Oncol. Biol. Phys., 48: 571-582, 2000.
28. Wykoff, C. C., Beasley, N. J. P., Watson, P. H., Turner, K. J., Pastorek, J., Sibtain, A., Wilson, G., D., Turley, H., Talks, K. L., Maxwell. P. H., Pugh, C. W., Ratcliffe. P. J., and Harris, A. L. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res., 60: 7075-7083, 2000.
29. Beasley, N. J. P., Wykoff. C. C., Watson, P. H., Leek, R., Turley, H., Gatter, K., Pastorek, J., Cox, G. J., Ratcliffe, P., and Harris, A. L. Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res., 61: 5262-5267, 2001.
30. Gross, M. W., Karbach, U., Groebe, K., Franko, A. J., and Mueller-Klieser, W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int. J. Cancer, 61: 567-573, 1995.
31. Arteel, G. E., Thurman, R. G., Yates, J. M., and Raleigh, J. A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer, 72: 889-895. 1995.
32. Ljungkvist, A. S. E., Bussink, J., Rijken, P. F. J. W., Raleigh, J. A., Denekamp, J., and van der Kogel, A. J. Changes in tumor hypoxia measured with a double hypoxic marker technique. Int. J. Radiat. Oncol. Biol. Phys., 48: 1529-1538, 2000.
33. Vukovic, V., Haugland, H. K., Nicklee, T., Morrison, A. J., and Hedley, D. W. Hypoxia-inducible factor-1α is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res., 61: 7394-7398, 2001.
34. Aebersold, D. M., Burri, P., Beer, K. T., Laissue, J., Djonov, V., Greiner, R. H., and Semenza, G. L. Expression of hypoxia-inducible factor-1α: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res., 61: 2911-2916, 2001.
35. Jenssen, N., Boysen, M., Kjaerheim, A., and Bryne, M. Low vascular density indicates poor response to radiotherapy in small glottic carcinomas. Pathol. Res. Pract., 192: 1090-1094, 1996.
36. Aebersold, D. M., Beer, K. T., Laissue, J., Hug, S., Kollar, A., Greiner, R. H., and Djonov, V. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int. J. Radiat. Oncol. Biol. Phys., 48: 17-25, 2000.
37. Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., and Fezoulidis, I. Cancer vascularization: Implications in radiotherapy? Int. J. Radiat. Oncol. Biol. Phys., 48: 545-553, 2000.
38. Brewer, C. A., Liao, S. Y., Wilczynski, S. P., Pastorekova, S., Pastorek, J., Zavada, J., Kurosaki, T., Manetta, A., Berman, M. L., DiSaia, P. J., and Stanbridge, E. J. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. Gynecol. Oncol., 63: 337-344, 1996.